abrdn Life Sciences Investors
CIK: 0000884121
HQL
Equity
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | ABEO Abeona Therapeutics Inc Since 2026-05-10 | 00289Y206 | Equity (Common) |
0.58%
|
$3.25 | 616,413 |
| 2 | JBIO Jade Biosciences Inc Since 2026-05-10 | 008064206 | Equity (Common) |
0.77%
|
$4.28 | 277,555 |
| 3 | ALLO Allogene Therapeutics Inc Since 2026-05-10 | 019770106 | Equity (Common) |
0.51%
|
$2.86 | 2,086,332 |
| 4 | ALNY Alnylam Pharmaceuticals Inc Since 2026-05-10 | 02043Q107 | Equity (Common) |
2.06%
|
$11.42 | 28,726 |
| 5 | AMGN Amgen Inc Since 2026-05-10 | 031162100 | Equity (Common) |
3.99%
|
$22.15 | 67,677 |
| 6 | APGE Apogee Therapeutics Inc Since 2026-05-10 | 03770N101 | Equity (Common) |
0.49%
|
$2.73 | 36,103 |
| 7 | AQST Aquestive Therapeutics Inc Since 2026-05-10 | 03843E104 | Equity (Common) |
0.30%
|
$1.65 | 255,905 |
| 8 | ACLX Arcellx Inc Since 2026-05-10 | 03940C100 | Equity (Common) |
0.23%
|
$1.27 | 19,562 |
| 9 | RCUS Arcus Biosciences Inc Since 2026-05-10 | 03969F109 | Equity (Common) |
0.26%
|
$1.44 | 60,608 |
| 10 | ARQT Arcutis Biotherapeutics Inc Since 2026-05-10 | 03969K108 | Equity (Common) |
0.75%
|
$4.19 | 144,311 |
| 11 | ARWR Arrowhead Pharmaceuticals Inc Since 2026-05-10 | 04280A100 | Equity (Common) |
1.44%
|
$7.99 | 120,388 |
| 12 | AVTX Avalo Therapeutics Inc Since 2026-05-10 | 05338F306 | Equity (Common) |
0.31%
|
$1.73 | 95,426 |
| 13 | AXSM Axsome Therapeutics Inc Since 2026-05-10 | 05464T104 | Equity (Common) |
1.30%
|
$7.23 | 39,565 |
| 14 | BCRX BioCryst Pharmaceuticals Inc Since 2026-05-10 | 09058V103 | Equity (Common) |
0.26%
|
$1.47 | 187,803 |
| 15 | CRBU Caribou Biosciences Inc Since 2026-05-10 | 142038108 | Equity (Common) |
0.40%
|
$2.21 | 1,388,905 |
| 16 | CDXS Codexis Inc Since 2026-05-10 | 192005106 | Equity (Common) |
0.80%
|
$4.46 | 2,734,032 |
| 17 | CRBP Corbus Pharmaceuticals Holdings Inc Since 2026-05-10 | 21833P301 | Equity (Common) |
0.80%
|
$4.43 | 543,719 |
| 18 | CRNX Crinetics Pharmaceuticals Inc Since 2026-05-10 | 22663K107 | Equity (Common) |
2.22%
|
$12.34 | 265,141 |
| 19 | DNLI Denali Therapeutics Inc Since 2026-05-10 | 24823R105 | Equity (Common) |
2.15%
|
$11.92 | 721,733 |
| 20 | IRON Disc Medicine Inc Since 2026-05-10 | 254604101 | Equity (Common) |
0.88%
|
$4.86 | 61,234 |
| 21 | DYN Dyne Therapeutics Inc Since 2026-05-10 | 26818M108 | Equity (Common) |
2.32%
|
$12.90 | 659,460 |
| 22 | EWTX Edgewise Therapeutics Inc Since 2026-05-10 | 28036F105 | Equity (Common) |
1.58%
|
$8.75 | 352,615 |
| 23 | EQ Equillium Inc Since 2026-05-10 | 29446K106 | Equity (Common) |
0.66%
|
$3.67 | 2,366,688 |
| 24 | EVMN Evommune Inc Since 2026-05-10 | 30054Y107 | Equity (Common) |
0.54%
|
$2.99 | 174,581 |
| 25 | EYPT EyePoint Inc Since 2026-05-10 | 30233G209 | Equity (Common) |
1.77%
|
$9.82 | 537,447 |
| 26 | FULC Fulcrum Therapeutics Inc Since 2026-05-10 | 359616109 | Equity (Common) |
2.55%
|
$14.18 | 1,254,027 |
| 27 | GILD Gilead Sciences Inc Since 2026-05-10 | 375558103 | Equity (Common) |
0.47%
|
$2.62 | 21,337 |
| 28 | GRAL GRAIL Inc Since 2026-05-10 | 384747101 | Equity (Common) |
0.64%
|
$3.56 | 41,603 |
| 29 | GH Guardant Health Inc Since 2026-05-10 | 40131M109 | Equity (Common) |
0.65%
|
$3.60 | 35,219 |
| 30 | IDYA Ideaya Biosciences Inc Since 2026-05-10 | 45166A102 | Equity (Common) |
1.34%
|
$7.44 | 215,279 |
| 31 | IMVT Immunovant Inc Since 2026-05-10 | 45258J102 | Equity (Common) |
2.02%
|
$11.22 | 441,498 |
| 32 | IMUX Immunic Inc Since 2026-05-10 | 4525EP101 | Equity (Common) |
0.29%
|
$1.62 | 3,028,916 |
| 33 | IONS Ionis Pharmaceuticals Inc Since 2026-05-10 | 462222100 | Equity (Common) |
0.41%
|
$2.29 | 28,926 |
| 34 | IOVA Iovance Biotherapeutics Inc Since 2026-05-10 | 462260100 | Equity (Common) |
0.37%
|
$2.07 | 759,522 |
| 35 | KRYS Krystal Biotech Inc Since 2026-05-10 | 501147102 | Equity (Common) |
0.63%
|
$3.48 | 14,121 |
| 36 | LENZ LENZ Therapeutics Inc Since 2026-05-10 | 52635N103 | Equity (Common) |
0.45%
|
$2.49 | 155,610 |
| 37 | NBIX Neurocrine Biosciences Inc Since 2026-05-10 | 64125C109 | Equity (Common) |
0.51%
|
$2.85 | 20,093 |
| 38 | NUVL Nuvalent Inc Since 2026-05-10 | 670703107 | Equity (Common) |
1.26%
|
$6.97 | 69,310 |
| 39 | ORKA Oruka Therapeutics Inc Since 2026-05-10 | 687604108 | Equity (Common) |
0.41%
|
$2.29 | 75,680 |
| 40 | PSNL Personalis Inc Since 2026-05-10 | 71535D106 | Equity (Common) |
1.94%
|
$10.78 | 1,354,053 |
| 41 | PRAX Praxis Precision Medicines Inc Since 2026-05-10 | 74006W207 | Equity (Common) |
0.95%
|
$5.25 | 17,814 |
| 42 | DTIL Precision BioSciences Inc Since 2026-05-10 | 74019P207 | Equity (Common) |
0.78%
|
$4.34 | 1,043,752 |
| 43 | REGN Regeneron Pharmaceuticals Inc Since 2026-05-10 | 75886F107 | Equity (Common) |
3.80%
|
$21.09 | 27,329 |
| 44 | RVMD Revolution Medicines Inc Since 2026-05-10 | 76155X100 | Equity (Common) |
0.53%
|
$2.92 | 36,678 |
| 45 | SRPT Sarepta Therapeutics Inc Since 2026-05-10 | 803607100 | Equity (Common) |
1.61%
|
$8.96 | 416,313 |
| 46 | STTK Shattuck Labs Inc Since 2026-05-10 | 82024L103 | Equity (Common) |
0.35%
|
$1.94 | 531,177 |
| 47 | SPRY ARS Pharmaceuticals Inc Since 2026-05-10 | 82835W108 | Equity (Common) |
1.22%
|
$6.77 | 581,057 |
| 48 | SION Sionna Therapeutics Inc Since 2026-05-10 | 829401108 | Equity (Common) |
1.88%
|
$10.47 | 254,414 |
| 49 | SLNO Soleno Therapeutics Inc Since 2026-05-10 | 834203309 | Equity (Common) |
0.81%
|
$4.51 | 97,455 |
| 50 | SMMT Summit Therapeutics Inc Since 2026-05-10 | 86627T108 | Equity (Common) |
1.02%
|
$5.68 | 324,733 |
| 51 | SNDX Syndax Pharmaceuticals Inc Since 2026-05-10 | 87164F105 | Equity (Common) |
1.41%
|
$7.83 | 372,792 |
| 52 | TSHA Taysha Gene Therapies Inc Since 2026-05-10 | 877619106 | Equity (Common) |
1.01%
|
$5.62 | 1,021,063 |
| 53 | TECX Tectonic Therapeutic Inc Since 2026-05-10 | 878972108 | Equity (Common) |
1.39%
|
$7.74 | 370,884 |
| 54 | TEM Tempus AI Inc Since 2026-05-10 | 88023B103 | Equity (Common) |
1.00%
|
$5.58 | 94,511 |
| 55 | TVTX Travere Therapeutics Inc Since 2026-05-10 | 89422G107 | Equity (Common) |
1.42%
|
$7.87 | 205,865 |
| 56 | TCRX TScan Therapeutics Inc Since 2026-05-10 | 89854M101 | Equity (Common) |
0.17%
|
$0.94 | 941,693 |
| 57 | RARE Ultragenyx Pharmaceutical Inc Since 2026-05-10 | 90400D108 | Equity (Common) |
2.06%
|
$11.43 | 497,078 |
| 58 | PCVX Vaxcyte Inc Since 2026-05-10 | 92243G108 | Equity (Common) |
2.62%
|
$14.54 | 315,222 |
| 59 | VIR Vir Biotechnology Inc Since 2026-05-10 | 92764N102 | Equity (Common) |
0.56%
|
$3.08 | 511,363 |
| 60 | IMUX IMMUNIC INC. Since 2026-05-10 | — | Derivative | — | — | 2,311,826 |
| 61 | IMUX IMMUNIC INC. Since 2026-05-10 | — | Derivative |
0.22%
|
$1.23 | 2,311,826 |
| 62 | IMUX IMMUNIC INC. Since 2026-05-10 | — | Derivative |
0.08%
|
$0.46 | 2,311,826 |
| 63 | XENE Xenon Pharmaceuticals Inc Since 2026-05-10 | 98420N105 | Equity (Common) |
2.15%
|
$11.92 | 266,030 |
| 64 | DTIL PRECISION BIOSCIENCES Since 2026-05-10 | — | Derivative |
0.14%
|
$0.78 | 336,267 |
| 65 | BHVN Biohaven Ltd Since 2026-05-10 | — | Equity (Common) |
1.41%
|
$7.83 | 693,452 |
| 66 | JAZZ Jazz Pharmaceuticals PLC Since 2026-05-10 | — | Equity (Common) |
0.39%
|
$2.18 | 12,845 |
| 67 | OCS Oculis Holding AG Since 2026-05-10 | — | Equity (Common) |
0.91%
|
$5.07 | 253,740 |